Search
for
Did you mean BRAF inhibitors?
Sort by
Research 30 of 334
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
- Diseases of the Canine Prostate Gland
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
- Is knowledge about the genetic and epigenetic alterations in melanoma a basis for targeted therapy?
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Biological therapy in the treatment of melanoma
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF V 600R mutation
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Redefining hormone resistance in prostate cancer
- The PDGF/PDGFR pathway as a drug target
- Male androgenetic alopecia (Part II)
- A computationally inferred regulatory heart aging model including post-transcriptional regulations
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Regulation of melanocyte stem cell behavior by the niche microenvironment
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- B-Raf and C-Raf Are Required for Melanocyte Stem Cell Self-Maintenance
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer
- Fgf21 Deficiency Delays Hair Follicle Cycling and Modulates miRNA–Target Gene Interactions in Mice
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors